O’Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402.
Khan HL, Bhatti S, Abbas S, Kaloglu C, Isa AM, Younas H, et al. Extracellular microRNAs: key players to explore the outcomes of in vitro fertilization. Reprod Biol Endocrinol. 2021;19(1):1–17.
Santamaria X, Taylor H. MicroRNA and gynecological reproductive diseases. Fertil Steril. 2014;101(6):1545–51.
Article CAS PubMed Google Scholar
Brunetti M, Panagopoulos I, Vitelli V, Andersen K, Hveem TS, Davidson B, et al. Endometrial carcinoma: molecular cytogenetics and transcriptomic profile. Cancers. 2022;14(14):3536.
Article CAS PubMed PubMed Central Google Scholar
Monk BJ, Tan DS, Chagüi JDH, Takyar J, Paskow MJ, Nunes AT, et al. Proportions and incidence of locally advanced cervical cancer: a global systematic literature review. Int J Gynecol Cancer. 2022. https://doi.org/10.1136/ijgc-2022-003801.
Article PubMed PubMed Central Google Scholar
Zhu JW, Charkhchi P, Akbari MR. Potential clinical utility of liquid biopsies in ovarian cancer. Mol Cancer. 2022;21(1):1–24.
Zhang D, Wang L, Guo HL, Zhang ZW, Wang C, Chian RC, et al. MicroRNA-202 inhibits endometrial stromal cell migration and invasion by suppressing the K-Ras/Raf1/MEK/ERK signaling pathway. Int J Mol Med. 2020;46(6):2078–88.
Article CAS PubMed PubMed Central Google Scholar
Zheng Y, Xie L, Xu S, Yan W, Zhang H, Meng Y, et al. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial–mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation. Mol Cell Biochem. 2021;476(11):4031–44.
Article CAS PubMed Google Scholar
Yi Y, Li H, Lv Q, Wu K, Zhang W, Zhang J, et al. miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1. Oncotarget. 2016;7(44):72067.
Article PubMed PubMed Central Google Scholar
Deng X, Hou C, Liang Z, Wang H, Zhu L, Xu H. miR-202 suppresses cell proliferation by targeting FOXR2 in endometrial adenocarcinoma. Dis mark. 2017. https://doi.org/10.1155/2017/2827435.
Zhang M, Zhang Y, Li L, Ma L, Zhou C. Dysregulation of miR-202-3p affects migration and invasion of endometrial stromal cells in endometriosis via targeting ROCK1. Reprod Sci. 2020;27(2):731–42.
Article CAS PubMed Google Scholar
Fassina A, Cappellesso R, Fassan M. Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. Chest. 2011;140(5):1305–11.
Article CAS PubMed Google Scholar
Yu H, Pan S. MiR-202-5p suppressed cell proliferation, migration and invasion in ovarian cancer via regulating HOXB2. Eur Rev Med Pharmacol Sci. 2020;24:2256–63.
Mallender WD, Yager D, Onstead L, Nichols MR, Eckman C, Sambamurti K, et al. Characterization of recombinant, soluble β-secretase from an insect cell expression system. Mol Pharmacol. 2001;59(3):619–26.
Article CAS PubMed Google Scholar
Wahid F, Shehzad A, Khan T. Kim YY 2010 MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochimica et Biophysica Acta (BBA)-Molecular Cell Res. 1803;11:1231–43.
Melamed ZE, Levy A, Ashwal-Fluss R, Lev-Maor G, Mekahel K, Atias N, et al. Alternative splicing regulates biogenesis of miRNAs located across exon-intron junctions. Mol cell. 2013;50(6):869–81.
Article CAS PubMed Google Scholar
Hoffman AE, Liu R, Fu A, Zheng T, Slack F, Zhu Y. Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesismiR-202 and lymphomagenesis. Cancer Epidemiol Biomark Prev. 2013;22(3):327–36.
Bizuayehu TT, Babiak I. MicroRNA in teleost fish. Genome Biol Evol. 2014;6(8):1911–37.
Article PubMed PubMed Central Google Scholar
Di Fiore R, Suleiman S, Pentimalli F, O’toole SA, O’leary JJ, Ward MP, et al. Could MicroRNAs be useful tools to improve the diagnosis and treatment of rare gynecological cancers? A brief overview. Int j mol sci. 2021;22(8):3822.
Article PubMed PubMed Central Google Scholar
Wongwarangkana C, Fujimori KE, Akiba M, Kinoshita S, Teruya M, Nezuo M, et al. Deep sequencing, profiling and detailed annotation of microRNAs in Takifugu rubripes. BMC Genomics. 2015;16(1):1–14.
Rosa A, Brivanlou AH. Regulatory non-coding RNAs in pluripotent stem cells. Int J Mol Sci. 2013;14(7):14346–73.
Article PubMed PubMed Central Google Scholar
Ahmed EA, Rajendran P, Scherthan H. The microRNA-202 as a diagnostic biomarker and a potential tumor suppressor. Int J Mol Sci. 2022;23(11):5870.
Article CAS PubMed PubMed Central Google Scholar
Hashemipour M, Boroumand H, Mollazadeh S, Tajiknia V, Nourollahzadeh Z, Borj MR, et al. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers. Gynecol Oncol. 2021;161(1):314–27.
Article CAS PubMed Google Scholar
Ledford LR, Lockwood S, editors. Scope and epidemiology of gynecologic cancers: an overview. Seminars in oncology nursing; 2019: Elsevier.
Mills AM, Bullock TN, Ring KL. Targeting immune checkpoints in gynecologic cancer: updates & perspectives for pathologists. Mod Pathol. 2022;35(2):142–51.
Article CAS PubMed Google Scholar
Razavi ZS, Tajiknia V, Majidi S, Ghandali M, Mirzaei HR, Rahimian N, et al. Gynecologic cancers and non-coding RNAs: epigenetic regulators with emerging roles. Crit Rev Oncol Hematol. 2021;157: 103192.
Wang Q, Peng H, Qi X, Wu M, Zhao X. Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence. Signal Transduct Target Ther. 2020;5(1):137.
Article PubMed PubMed Central Google Scholar
Gonçalves V. Long-term quality of life in gynecological cancer survivors. Curr Opin Obstet Gynecol. 2010;22(1):30–5.
Crusz SM, Miller RE. Targeted therapies in gynaecological cancers. Histopathology. 2020;76(1):157–70.
De Almeida BC, Garcia N, Maffazioli G, Gonzalez dos Anjos L, ChadaBaracat E, CandidoCarvalho K. Oncomirs expression profiling in uterine leiomyosarcoma cells. Int j mol sci. 2017;19(1):52.
Article PubMed PubMed Central Google Scholar
Kim J, Park S, Hwang D, Kim SI, Lee H. Diagnostic value of circulating miR-202 in early-stage breast cancer in South Korea. Medicina. 2020;56(7):340.
Article PubMed PubMed Central Google Scholar
Zheng Y, Xie L, Xu S, Yan W, Zhang H, Meng Y, et al. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial–mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation. Mol Cell Biochem. 2021;476:4031–44.
Article CAS PubMed Google Scholar
Chang RK, Li X, Mu N, Hrydziuszko O, Garcia-Majano B, Larsson C, et al. MicroRNA expression profiles in non-epithelial ovarian tumors. Int J Oncol. 2018;52(1):55–66.
Yu H, Pan S. MiR-202–5p suppressed cell proliferatio
Comments (0)